scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference

BURLINGTON, Mass., Feb. 06, 2018 -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer of scPharmaceuticals, will present at the 7^th Annual Leerink Partners Global Healthcare Conference at 11:30 a.m. ET on Thursday, February 15, 2018, at the Westin Grand Central Hotel in New York, NY.

Investors interested in arranging a meeting with the Company’s management during this conference should contact the conference coordinator.

About scPharmaceuticals
scPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs. Our proprietary platform is designed to enable the subcutaneous administration of therapies that have previously been limited to intravenous (IV) delivery.

Contacts:

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
[email protected] 

Christopher F. Brinzey
Westwicke Partners, 339-970-2843
[email protected]